<p>，/PRNewswire/ -- Ademi 律師事務所正在調查 Generation Bio（納斯達克：GBIO）在其最近宣佈與 XOMA Royalty Corporation 交易中可能存在的信託責任違反和其他法律違規行為。</p>
<p>點擊這裏瞭解如何加入我們的調查並獲取更多信息，或通過 [email protected] 與我們聯繫，或撥打免費電話：866-264-3995。您無需支付任何費用或承擔任何義務。</p>
<p>在此次交易中，Generation Bio 的股東將每股獲得 4.2913 美元現金以及每股一個附帶價值權。附帶價值權將使持有者有權在交易完成時獲得超過 2900 萬美元的淨現金部分、Generation Bio 在劍橋辦公室租賃義務中的潛在節省，以及 Generation Bio 與 Moderna 現有許可協議的收益，該協議包括開發和商業里程碑及版税。</p>
<p>Generation Bio 的內部人士將在控制權變更安排中獲得可觀的利益。</p>
<p>交易協議不合理地限制了 Generation Bio 的競爭交易，若 Generation Bio 接受競爭報價將面臨重大罰款。我們正在調查 Generation Bio 董事會的行為，以及他們是否履行了對所有股東的信託責任。</p>
<p>我們專注於涉及收購、合併和個人股東權利的股東訴訟。如需更多信息，請隨時與我們聯繫。律師廣告。以往的結果並不保證類似的結果。</p>
<p>聯繫方式</p>
<p>Ademi &amp; Fruchter LLP</p>
<p>Guri Ademi</p>
<p>免費電話：（866）264-3995</p>
<p>傳真：（414）482-8001</p>
<p>來源：Ademi LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Q0c0ODE0NiZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUyMDIxUFJfTkVXU19VU1BSX19fX19DRzQ4MTQ2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Q0c0ODE0NiZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUyMDIxUFJfTkVXU19VU1BSX19fX19DRzQ4MTQ2"/></p>

GBIO

<p>Ademi 律師事務所正在調查 Generation Bio 在與 XOMA Royalty Corporation 交易中是否存在潛在的信託責任違規行為。股東將獲得每股 4.2913 美元的現金以及附帶的價值權利。該交易限制了競爭性出價，並使內部人士受益。調查的重點是董事會是否履行了其信託責任。如需更多信息，請聯繫 Ademi & Fruchter LLP</p>

<p>, /PRNewswire/ -- The Ademi Firm is investigating Generation Bio (Nasdaq: GBIO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XOMA Royalty Corporation.</p>
<div class="lb-trans"><p>，/PRNewswire/ -- Ademi 律師事務所正在調查 Generation Bio（納斯達克：GBIO）在其最近宣佈與 XOMA Royalty Corporation 交易中可能存在的信託責任違反和其他法律違規行為。</p>
</div><p>Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.</p>
<div class="lb-trans"><p>點擊這裏瞭解如何加入我們的調查並獲取更多信息，或通過 [email protected] 與我們聯繫，或撥打免費電話：866-264-3995。您無需支付任何費用或承擔任何義務。</p>
</div><p>In the transaction, Generation Bio shareholders will own $4.2913 per share in cash plus one contingent value right per share. The CVRs will entitle holders to receive portions of net cash above $29 million at closing, potential savings from Generation Bio's Cambridge office lease obligations, and proceeds from Generation Bio's existing license agreement with Moderna, which includes development and commercial milestones and royalties.</p>
<div class="lb-trans"><p>在此次交易中，Generation Bio 的股東將每股獲得 4.2913 美元現金以及每股一個附帶價值權。附帶價值權將使持有者有權在交易完成時獲得超過 2900 萬美元的淨現金部分、Generation Bio 在劍橋辦公室租賃義務中的潛在節省，以及 Generation Bio 與 Moderna 現有許可協議的收益，該協議包括開發和商業里程碑及版税。</p>
</div><p>Generation Bio insiders will receive substantial benefits as part of change of control arrangements.</p>
<div class="lb-trans"><p>Generation Bio 的內部人士將在控制權變更安排中獲得可觀的利益。</p>
</div><p>The transaction agreement unreasonably limits competing transactions for Generation Bio by imposing a significant penalty if Generation Bio accepts a competing bid. We are investigating the conduct of the Generation Bio board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.</p>
<div class="lb-trans"><p>交易協議不合理地限制了 Generation Bio 的競爭交易，若 Generation Bio 接受競爭報價將面臨重大罰款。我們正在調查 Generation Bio 董事會的行為，以及他們是否履行了對所有股東的信託責任。</p>
</div><p>We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.</p>
<div class="lb-trans"><p>我們專注於涉及收購、合併和個人股東權利的股東訴訟。如需更多信息，請隨時與我們聯繫。律師廣告。以往的結果並不保證類似的結果。</p>
</div><p>Contacts</p>
<div class="lb-trans"><p>聯繫方式</p>
</div><p>Ademi &amp; Fruchter LLP</p>
<div class="lb-trans"><p>Ademi &amp; Fruchter LLP</p>
</div><p>Guri Ademi</p>
<div class="lb-trans"><p>Guri Ademi</p>
</div><p>Toll Free: (866) 264-3995</p>
<div class="lb-trans"><p>免費電話：（866）264-3995</p>
</div><p>Fax: (414) 482-8001</p>
<div class="lb-trans"><p>傳真：（414）482-8001</p>
</div><p>SOURCE Ademi LLP</p>
<div class="lb-trans"><p>來源：Ademi LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMjE1Jk5ld3NJdGVtSWQ9Q0c0ODE0NiZUcmFuc21pc3Npb25fSWQ9MjAyNTEyMTUyMDIxUFJfTkVXU19VU1BSX19fX19DRzQ4MTQ2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=CG48146&amp;Transmission_Id=202512152021PR_NEWS_USPR_____CG48146&amp;DateId=20251215"/></p>

股東警示：Ademi 公司正在調查 Generation Bio Co.是否為其公眾股東爭取到了公平的價格